Insights

Market Need Target a niche in breast reconstruction by offering off-the-shelf acellular NAC grafts to plastic and reconstructive surgeons, aligning with the company’s focus on post-mastectomy reconstruction.

Clinical Expansion Leverage ongoing pre-clinical and upcoming clinical studies for NACgraft and pelvic organ prolapse grafts to pursue multi-site trials and expand indications, driving adoption among surgeons and institutions.

Funding Momentum Highlight recent Series A financing and grants to engage VCs and grant programs for larger manufacturing scale, regulatory milestones, and collaborative research with hospitals.

Strategic Partnerships Propose partnerships with large aesthetics players or academic medical centers to co-develop and validate NAC grafts, leveraging Tulane-origin credibility and existing investor interest.

Global Reach Explore international distribution through surgical networks and OEM manufacturing agreements, positioning NAC grafts as standardized, accessible solutions for reconstructive surgeons worldwide.

Similar companies to BioAesthetics

BioAesthetics Tech Stack

BioAesthetics uses 8 technology products and services including Google AdSense, iCIMS, WordPress, and more. Explore BioAesthetics's tech stack below.

Media & News

BioAesthetics's Email Address Formats

BioAesthetics uses at least 1 email format:
BioAesthetics Email FormatsExamplePercentage
FLast@bio-aesthetics.comJDoe@bio-aesthetics.com
100%

Frequently Asked Questions

What is BioAesthetics's official website and social media links?

Minus sign iconPlus sign icon
BioAesthetics's official website is bio-aesthetics.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does BioAesthetics generate?

Minus sign iconPlus sign icon
As of July 2026, BioAesthetics's annual revenue is estimated to be $1M - $10M.

What is BioAesthetics's SIC code and NAICS code?

Minus sign iconPlus sign icon
BioAesthetics's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BioAesthetics have currently?

Minus sign iconPlus sign icon
As of July 2026, BioAesthetics has approximately 13 employees across 2 continents, including North America and Europe. Key team members include Chief Operating Officer: F. B., Founder And Chief Executive Officer: N. P. and Quality Director: J. D. Explore BioAesthetics's employee directory with LeadIQ.

What industry does BioAesthetics belong to?

Minus sign iconPlus sign icon
BioAesthetics operates in the Biotechnology Research industry.

What technology does BioAesthetics use?

Minus sign iconPlus sign icon
BioAesthetics's tech stack includes Google AdSense, iCIMS, WordPress, Shopify, Google Workspace, Agentforce, Netlify and Piwik PRO Core.

What is BioAesthetics's email format?

Minus sign iconPlus sign icon
BioAesthetics's email format typically follows the pattern of FLast@bio-aesthetics.com. Find more BioAesthetics email formats with LeadIQ.

How much funding has BioAesthetics raised to date?

Minus sign iconPlus sign icon
As of July 2026, BioAesthetics has raised $6.7M in funding. The last funding round occurred on Sep 26, 2023.

When was BioAesthetics founded?

Minus sign iconPlus sign icon
BioAesthetics was founded in 2015.
BioAesthetics logo

BioAesthetics

Biotechnology ResearchNorth Carolina, United States11-50 Employees

BioAesthetics is a small biotechnology company based in Durham, North Carolina, founded in 2015 as a Tulane University spin-out with the aim of expanding reconstructive options for breast cancer patients after mastectomy. It is developing a tissue-engineered nipple-areolar complex graft that surgeons can use off the shelf during breast reconstruction; the graft is acellular and is designed to be implanted onto the reconstructed breast, with the body’s tissues regenerating the nipple-areolar area around it. The product is patent-pending and in the pre-clinical stage, and its primary customers are plastic and reconstructive surgeons and their patients undergoing reconstruction after mastectomy. 

BioAesthetics operates within the biotechnology research sector, focusing on biomaterials for reconstructive medicine. A notable recent development is the appointment of Juliana Blum, Ph.D., as chief executive officer in September 2024. The company’s activities center on advancing nipple reconstruction options within breast reconstruction procedures.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
11-50

Section iconFunding & Financials

  • $6.7M

    BioAesthetics has raised a total of $6.7M of funding over 7 rounds. Their latest funding round was raised on Sep 26, 2023 as a Convertible Note.

  • $1M - $10M

    BioAesthetics's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.